Vanessa Bolejack

Vanessa Bolejack

UNVERIFIED PROFILE

Are you Vanessa Bolejack?   Register this Author

Register author
Vanessa Bolejack

Vanessa Bolejack

Publications by authors named "Vanessa Bolejack"

Are you Vanessa Bolejack?   Register this Author

39Publications

1187Reads

6Profile Views

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.

J Clin Oncol 2019 Jun 23;37(16):1424-1431. Epub 2019 Apr 23.

16 Monter Cancer Center, Northwell Health, Lake Success, NY, and Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.02374DOI Listing
June 2019

PD-1 inhibition in sarcoma still needs investigation - Authors' reply.

Lancet Oncol 2018 01;19(1):e7

Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30922-1DOI Listing
January 2018

The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer.

J Thorac Oncol 2017 07 28;12(7):1109-1121. Epub 2017 Apr 28.

Thoracic Surgery Service, Hospital Universitari Mutua Terrassa, University of Barcelona; Centros de Investigación Biomédica en Red de Enfermedades Respiratorias CIBERES Lung Cancer Group, Terrassa, Barcelona, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864173034
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2017.04.011DOI Listing
July 2017

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

J Clin Oncol 2016 Oct;34(30):3680-3685

Vadim S. Koshkin, Cleveland Clinic, Cleveland, OH; Vanessa Bolejack, Cancer Research and Biostatistics, Seattle, WA; Lawrence H. Schwartz, Binsheng Zhao, Columbia University Medical Center, New York, NY; Richard L. Wahl, Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, MO; Rashmi Chugh, Scott M. Schuetze, Laurence H. Baker, University of Michigan Medical School; Denise K. Reinke, Sarcoma Alliance for Research Through Collaboration, Ann Arbor, MI; Joo H. O, The Catholic University of Korea; Seoul St Mary's Hospital, Seoul, Republic of Korea; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065114PMC
October 2016

The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer.

J Thorac Oncol 2016 09 21;11(9):1433-46. Epub 2016 Jul 21.

Thoracic Surgery Service, Hospital Universitari Mutua Terrassa and Centros de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.06.028DOI Listing
September 2016

Reply to "Inclusion of Lymphangitis as a Descriptor in the New TNM Staging of Lung Cancer: Filling Up the Blank Spaces".

J Thorac Oncol 2015 Dec;10(12):e119-20

Department of Thoracic Surgery, Hospital Universitari Mútua Terrassa, University of Barcelona, Barcelona, SpainCancer Research And Biostatistics, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000683DOI Listing
December 2015

The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):990-1003

*Department of Thoracic Surgery, Hospital Universitari Mútua Terrassa, University of Barcelona, and CIBERES Lung Cancer Group, Terrassa, Barcelona, Spain; †Cancer Research And Biostatistics, Seattle, Washington; ‡Department of Radiotherapy, Peter MacCallum Cancer Centre, Melbourne, Australia; §Department of Thoracic Surgery, Samsung Medical Center, Seoul, South Korea; ‖Department of Thoracic Surgery, Hospital Británico, Buenos Aires, Argentina; ¶Department of Thoracic Surgery, Cleveland Clinic, Cleveland, Ohio; #Department of Thoracic Surgery, Juntendo University, Tokyo, Japan; **Department of Internal Medicine and Pulmonology, Mayo Clinic, Rochester, Minnesota; ††Department of Pathology, Sloan-Kettering Cancer Center, New York, New York; ‡‡Guangdong Lung Cancer Institute, Guangdong, General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China; and §§Members of the IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions are listed in the Appendix.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000559DOI Listing
July 2015

The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer.

J Thorac Oncol 2014 Nov;9(11):1618-24

*Department of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona; †CIBERES Lung Cancer Group, Terrassa, Barcelona, Spain; ‡Cancer Research And Biostatistics, Seattle, WA; §Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan; and ‖Department of Thoracic Surgery, Royal Brompton Hospital and Imperial College, London, United Kingdom; ¶Members of the Staging and Prognostic Factors Committee are listed in the Appendix 1.

View Article

Download full-text PDF

Source
http://www.pneumonologia.gr/articlefiles/IASLC%20NSCLC.pdf
Web Search
http://www.slpneumo.lu/download/hot-topics/NewLymphNodeMap-N
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S155608641530728
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000334DOI Listing
November 2014

Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival.

Ann Hematol 2011 Apr 14;90(4):423-8. Epub 2010 Dec 14.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 West Markham #816, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-010-1130-y
Publisher Site
http://dx.doi.org/10.1007/s00277-010-1130-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053415PMC
April 2011

The new tumor, node, and metastasis staging system.

Semin Respir Crit Care Med 2011 Feb 15;32(1):44-51. Epub 2011 Apr 15.

Thoracic Surgery Service, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0031-1272868DOI Listing
February 2011

Standardized evaluation of regional and institutional breast cancer outcomes.

Am J Surg 2008 May 2;195(5):636-40; discussion 640. Epub 2008 Apr 2.

Department of Surgery, Swedish Cancer Institute, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2007.12.038DOI Listing
May 2008

High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.

Cancer 2008 Apr;112(8):1754-64

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652244PMC
April 2008

Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients.

Blood Coagul Fibrinolysis 2007 Oct;18(7):595-8

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e3281067fb2DOI Listing
October 2007

Immunotoxic effects of chemicals: A matrix for occupational and environmental epidemiological studies.

Am J Ind Med 2006 Dec;49(12):1046-55

Centre for Study and Cancer Prevention, Unit of Environmental and Occupational Epidemiology, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajim.20364DOI Listing
December 2006

Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma.

Clin Lymphoma Myeloma 2006 May;6(6):469-74

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.027DOI Listing
May 2006